Loading company…
The seven biotech assets are companies operating in areas including oncology, gene therapy and rare disease treatment.
The seven biotech assets formerly held by Schroder UK Public-Private Trust comprise companies working in areas including oncology, gene therapy, stem cell research and rare disease treatment. Revelation Partners and Rosetta Capital acquired them from Schroders in March 2021 for GBP 85 million.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Schroder UK Public-Private Trust's Seven Biotech Assets? This is my company